Cite
HARVARD Citation
Ferreri, A. et al. (2021). MYD88 L265P mutation and interleukin‐10 detection in cerebrospinal fluid are highly specific discriminating markers in patients with primary central nervous system lymphoma: results from a prospective study. British journal of haematology. pp. 497-505. [Online].